OTCMKTS:CHEOF Cochlear (CHEOF) Stock Price, News & Analysis $183.04 0.00 (0.00%) As of 08/22/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock About Cochlear Stock (OTCMKTS:CHEOF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cochlear alerts:Sign Up Key Stats Today's Range$183.04▼$183.0450-Day Range$181.00▼$207.7152-Week Range$148.62▼$209.27VolumeN/AAverage Volume167 shsMarket CapitalizationN/AP/E Ratio111.47Dividend Yield0.69%Price TargetN/AConsensus RatingN/A Company Overview Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia. Read More Cochlear Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks0th Percentile Overall ScoreCHEOF MarketRank™: Cochlear scored higher than 0% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Cochlear. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cochlear is 111.47, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.44.Price to Earnings Ratio vs. SectorThe P/E ratio of Cochlear is 111.47, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 31.36. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverCochlear has a short interest ratio ("days to cover") of 623, which indicates bearish sentiment.Change versus previous monthShort interest in Cochlear has recently increased by 18.67%, indicating that investor sentiment is decreasing significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldCochlear pays a meaningful dividend of 2.07%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthCochlear does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Cochlear is 77.34%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about Cochlear's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoverCochlear has a short interest ratio ("days to cover") of 623, which indicates bearish sentiment.Change versus previous monthShort interest in Cochlear has recently increased by 18.67%, indicating that investor sentiment is decreasing significantly. News and Social Media1.1 / 5News Sentiment-0.09 News SentimentCochlear has a news sentiment score of -0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cochlear this week, compared to 1 article on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cochlear insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 22.47% of the stock of Cochlear is held by institutions.Read more about Cochlear's insider trading history. Receive CHEOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address CHEOF Stock News HeadlinesCiti Sticks to Their Buy Rating for Cochlear (CHEOF)August 20, 2025 | theglobeandmail.comMorgan Stanley Remains a Sell on Cochlear (CHEOF)August 20, 2025 | theglobeandmail.comTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.August 24 at 2:00 AM | Porter & Company (Ad)Ord Minnett Reaffirms Their Hold Rating on Cochlear (CHEOF)August 20, 2025 | theglobeandmail.comCochlear Full Year 2025 Earnings: Misses ExpectationsAugust 17, 2025 | finance.yahoo.comCochlear tips higher earnings this year, slower first-halfAugust 14, 2025 | afr.comCochlear Limited Extends Share Buy-Back ProgramAugust 14, 2025 | tipranks.comCochlear Limited to Quote New Securities on ASXAugust 14, 2025 | tipranks.comSee More Headlines CHEOF Stock Analysis - Frequently Asked Questions How have CHEOF shares performed this year? Cochlear's stock was trading at $182.0528 on January 1st, 2025. Since then, CHEOF shares have increased by 0.5% and is now trading at $183.04. How do I buy shares of Cochlear? Shares of CHEOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:CHEOF CIK1453930 Webwww.cochlear.com Phone(129) 428-6555FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio111.47 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (OTCMKTS:CHEOF) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cochlear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.